Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/188732
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells

AutorAguado, Tania CSIC ORCID; Romero-Revilla, José A. CSIC; Granados, R.; Campuzano, Susana CSIC ORCID; Torrente-Rodríguez, Rebeca M.; Cuesta, Ángel M. CSIC ORCID ; Albiñana, Virginia CSIC; Botella, Luisa María CSIC ORCID ; Santamaría, Silvia CSIC ORCID; García-Sanz, José A. CSIC ORCID ; Pingarrón, José Manuel; Sánchez-Sancho, Francisco CSIC; Sánchez-Puelles, José María CSIC ORCID
Fecha de publicación15-ago-2019
EditorSpringer Nature
CitaciónSci Rep 9 (1) 11916 (2019)
ResumenPhenotypic drug discovery must take advantage of the large amount of clinical data currently available. In this sense, the impact of microRNAs (miRs) on human disease and clinical therapeutic responses is becoming increasingly well documented. Accordingly, it might be possible to use miR-based signatures as phenotypic read-outs of pathological status, for example in cancer. Here, we propose to use the information accumulating regarding the biology of miRs from clinical research in the preclinical arena, adapting it to the use of miR biosensors in the earliest steps of drug screening. Thus, we have used an amperometric dual magnetosensor capable of monitoring a miR-21/miR-205 signature to screen for new drugs that restore these miRs to non-tumorigenic levels in cell models of breast cancer and glioblastoma. In this way we have been able to identify a new chemical entity, 11PS04 ((3aR,7aS)-2-(3-propoxyphenyl)-7,7a-dihydro-3aH-pyrano[3,4-d]oxazol-6(4H)-one), the therapeutic potential of which was suggested in mechanistic assays of disease models, including 3D cell culture (oncospheres) and xenografts. These assays highlighted the potential of this compound to attack cancer stem cells, reducing the growth of breast and glioblastoma tumors in vivo. These data demonstrate the enhanced chain of translatability of this strategy, opening up new perspectives for drug-discovery pipelines and highlighting the potential of miR-based electro-analytical sensors as efficient tools in modern drug discovery.
Descripción13 p.-5 fig-1 tab.
Versión del editorhttps://doi.org/10.1038/s41598-019-48359-y
URIhttp://hdl.handle.net/10261/188732
DOI10.1038/s41598-019-48359-y
E-ISSN2045-2322
Aparece en las colecciones: (CIB) Artículos
(IQM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Scientific Reports_Aguado_2019.pdfArtículo principal3,06 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

1
checked on 06-mar-2024

SCOPUSTM   
Citations

2
checked on 16-mar-2024

WEB OF SCIENCETM
Citations

2
checked on 24-feb-2024

Page view(s)

233
checked on 17-mar-2024

Download(s)

118
checked on 17-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons